MedPath
HSA Approval

PARMOL 250 SUSPENSION 250 mg/5 ml

SIN05565P

PARMOL 250 SUSPENSION 250 mg/5 ml

PARMOL 250 SUSPENSION 250 mg/5 ml

March 20, 1991

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

PARACETAMOL

250 mg/5 ml

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PARMOL 250 SUSPENSION 250 mg/5 ml - HSA Approval | MedPath